Company profile for Seismic Therapeutic

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are The Machine Learning Immunology Company. Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biol...
We are The Machine Learning Immunology Company. Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Watertown, MA
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/15/3205356/0/en/Seismic-Therapeutic-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference-on-January-15-2026.html

GLOBENEWSWIRE
15 Dec 2025

https://www.businesswire.com/news/home/20250602827336/en/Seismic-Therapeutic-Appoints-Sophie-Jones-M.D.-as-Chief-Financial-Officer

BUSINESSWIRE
02 Jun 2025

https://www.businesswire.com/news/home/20250410416020/en/Seismic-Therapeutic-Doses-First-Cohort-in-Phase-1-Clinical-Trial-of-S-4321-a-Novel-Bifunctional-Antibody-that-Agonizes-PD-1-and-FcRIIb-Inhibitory-Receptors-for-the-Treatment-of-Autoimmune-Disease

BUSINESSWIRE
10 Apr 2025

https://www.businesswire.com/news/home/20250318796581/en/Seismic-Therapeutic-Forms-Translational-Medicine-Advisory-Board-with-Prominent-Experts-in-Immunology-Rheumatology-Dermatology-and-Neurology

BUSINESSWIRE
18 Mar 2025

https://www.businesswire.com/news/home/20250311555292/en

BUSINESSWIRE
11 Mar 2025

https://www.businesswire.com/news/home/20250228711198/en

BUSINESSWIRE
28 Feb 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty